Nuedexta Approval History

  • FDA approved: Yes (First approved October 29th, 2010)
  • Brand name: Nuedexta
  • Generic name: dextromethorphan and quinidine
  • Previous name: Zenvia
  • Company: Avanir Pharmaceuticals
  • Treatment for: Pseudobulbar Affect

Nuedexta (dextromethorphan and quinidine) is a first-in-class dual action glutamate inhibitor indicated for the treatment of pseudobulbar affect.

FDA Approval History for Nuedexta

DateArticle
Nov  1, 2010Approval Avanir Pharmaceuticals Announces FDA Approval of Nuedexta
May 17, 2010Avanir Pharmaceuticals Announces Zenvia Review Timeline Established by FDA with PDUFA Date of October 30, 2010
Apr 30, 2010AVANIR Pharmaceuticals Submits Complete Response to FDA Approvable Letter for Zenvia in PBA
Mar 16, 2009Zenvia Phase III PBA Trial Completes Patient Enrollment
Feb 27, 2007AVANIR Pharmaceuticals Announces Conference Call to Provide Zenvia FDA Meeting Update
Oct 31, 2006Avanir Receives FDA Approvable Letter for Zenvia for the Treatment of Involuntary Emotional Expression Disorder
Jun 19, 2006FDA Informs Avanir of Revised Neurodex NDA Action Date
Apr  4, 2006Avanir's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression Disorder
Jan 30, 2006Avanir Submits Expanded Neurodex New Drug Application for the Treatment of Involuntary Emotional Expression Disorder
Sep 22, 2005Further Update on Avanir's Neurodex New Drug Application
Jun 30, 2005Avanir Submits NDA for Neurodex
Dec 16, 2004AVANIR Announces Submission of Rolling NDA With Priority Review for Neurodex

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web3)